Unknown

Dataset Information

0

Exome sequencing supports a de novo mutational paradigm for schizophrenia.

ABSTRACT: Despite its high heritability, a large fraction of individuals with schizophrenia do not have a family history of the disease (sporadic cases). Here we examined the possibility that rare de novo protein-altering mutations contribute to the genetic component of schizophrenia by sequencing the exomes of 53 sporadic cases, 22 unaffected controls and their parents. We identified 40 de novo mutations in 27 cases affecting 40 genes, including a potentially disruptive mutation in DGCR2, a gene located in the schizophrenia-predisposing 22q11.2 microdeletion region. A comparison to rare inherited variants indicated that the identified de novo mutations show a large excess of non-synonymous changes in schizophrenia cases, as well as a greater potential to affect protein structure and function. Our analyses suggest a major role for de novo mutations in schizophrenia as well as a large mutational target, which together provide a plausible explanation for the high global incidence and persistence of the disease.

SUBMITTER: Xu B 

PROVIDER: S-EPMC3196550 | biostudies-literature | 2011 Aug

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Exome sequencing supports a de novo mutational paradigm for schizophrenia.

Xu Bin B   Roos J Louw JL   Dexheimer Phillip P   Boone Braden B   Plummer Brooks B   Levy Shawn S   Gogos Joseph A JA   Karayiorgou Maria M  

Nature genetics 20110807 9

Despite its high heritability, a large fraction of individuals with schizophrenia do not have a family history of the disease (sporadic cases). Here we examined the possibility that rare de novo protein-altering mutations contribute to the genetic component of schizophrenia by sequencing the exomes of 53 sporadic cases, 22 unaffected controls and their parents. We identified 40 de novo mutations in 27 cases affecting 40 genes, including a potentially disruptive mutation in DGCR2, a gene located  ...[more]

Similar Datasets

Unknown De novo mutations identified by exome sequencing implicate rare missense variants in SLC6A1 in schizophrenia.
| S-EPMC7007300 | biostudies-literature
Unknown Exome Sequencing Reveals De Novo Variants in Congenital Scoliosis.
| S-EPMC9578779 | biostudies-literature
Unknown Exome sequencing in schizophrenia-affected parent-offspring trios reveals risk conferred by protein-coding de novo mutations.
| S-EPMC7007385 | biostudies-literature
Unknown Exome sequencing to identify de novo mutations in sporadic ALS trios.
| S-EPMC3709464 | biostudies-literature
Unknown Whole-Exome Sequencing Identifies Damaging de novo Variants in Anencephalic Cases.
| S-EPMC6896715 | biostudies-literature
Unknown Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations.
| S-EPMC3115696 | biostudies-literature
Unknown Whole-exome sequencing for finding de novo mutations in sporadic mental retardation.
| S-EPMC3046476 | biostudies-literature
Unknown Exome sequencing of Japanese schizophrenia multiplex families supports the involvement of calcium ion channels.
| S-EPMC9089874 | biostudies-literature
Unknown De novo mutations revealed by whole-exome sequencing are strongly associated with autism.
| S-EPMC3667984 | biostudies-literature
Unknown Trio-based exome sequencing arrests de novo mutations in early-onset high myopia.
| S-EPMC5402409 | biostudies-literature